What does DR. VERCAMMEN CHRIS do?

DR. VERCAMMEN CHRIS is a specialist medical practice in Putte. Private Limited, started on 21 January 2000, 2 establishments.

What is the address of DR. VERCAMMEN CHRIS?

The registered office of DR. VERCAMMEN CHRIS is located at Wolzakken 22, 2580 Putte.

Is DR. VERCAMMEN CHRIS still active?

Yes. According to the CBE (31 October 2026) DR. VERCAMMEN CHRIS is active, legal situation “Normale toestand”, started on 21 January 2000.

Is DR. VERCAMMEN CHRIS registered on Peppol?

Yes, DR. VERCAMMEN CHRIS is registered on the Peppol network with ID 0208:0469941838.

What is the enterprise number of DR. VERCAMMEN CHRIS?

The enterprise number of DR. VERCAMMEN CHRIS is BE0469941838.

When was DR. VERCAMMEN CHRIS founded?

DR. VERCAMMEN CHRIS was founded on 21 January 2000.

Who are the directors of DR. VERCAMMEN CHRIS?

According to the 2025 annual accounts, the directors of DR. VERCAMMEN CHRIS are: Chris Vercammen.

Is DR. VERCAMMEN CHRIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. VERCAMMEN CHRIS make in 2025?

DR. VERCAMMEN CHRIS posted a profit after taxes of € 202,983 in financial year 2025.

What is the revenue of DR. VERCAMMEN CHRIS?

As a small company, DR. VERCAMMEN CHRIS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 292,163.

DR. VERCAMMEN CHRIS (Private Limited) - Putte

Dossier DR. VERCAMMEN CHRIS, printed on 31 October 2026 from databakkes.be/en/0469941838/dr-vercammen-chris. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 55 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. VERCAMMEN CHRIS from Putte, company number BE0469941838, closed financial year 2025 with a result of € 202,983 after tax. For that financial year DR. VERCAMMEN CHRIS recorded a gross margin of € 292,163 and equity of € 867,661. Compared with financial year 2024, the result moved from € 243,031 to € 202,983. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 867,661

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 202,983

▼ 16% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 29,628

▼ 95% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 68,700 paid out

34 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 38,817

▼ 23% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 38,675

▼ 41% vs 2024

€ 24,988 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 32,017

▼ 38% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 215,543 Gross margin 2022: € 215,543 First fiscal year in the series	€ 216,137 Gross margin 2023: € 216,137 Unchanged (€ 215,543) Favourable step	€ 253,768 Gross margin 2024: € 253,768 ▲ 17% vs 2023 (€ 216,137) Favourable step	€ 292,163 Gross margin 2025: € 292,163 ▲ 15% vs 2024 (€ 253,768) Favourable step	▲ 15%
Profit after taxes	€ 117,765 Profit after taxes 2022: € 117,765 First fiscal year in the series	€ 166,283 Profit after taxes 2023: € 166,283 ▲ 41% vs 2022 (€ 117,765) Favourable step	€ 243,031 Profit after taxes 2024: € 243,031 ▲ 46% vs 2023 (€ 166,283) Favourable step	€ 202,983 Profit after taxes 2025: € 202,983 ▼ 16% vs 2024 (€ 243,031) Unfavourable step	▼ 16%
Equity	€ 555,640 Equity 2022: € 555,640 First fiscal year in the series	€ 561,847 Equity 2023: € 561,847 ▲ 1% vs 2022 (€ 555,640) Favourable step	€ 733,377 Equity 2024: € 733,377 ▲ 31% vs 2023 (€ 561,847) Favourable step	€ 867,661 Equity 2025: € 867,661 ▲ 18% vs 2024 (€ 733,377) Favourable step	▲ 18%
Total debts	€ 114,202 Total debts 2022: € 114,202 First fiscal year in the series	€ 223,096 Total debts 2023: € 223,096 ▲ 95% vs 2022 (€ 114,202) Unfavourable step	€ 170,177 Total debts 2024: € 170,177 ▼ 24% vs 2023 (€ 223,096) Favourable step	€ 75,478 Total debts 2025: € 75,478 ▼ 56% vs 2024 (€ 170,177) Favourable step	▼ 56%
Cash	€ 41,356 Cash 2022: € 41,356 First fiscal year in the series	€ 54,925 Cash 2023: € 54,925 ▲ 33% vs 2022 (€ 41,356) Favourable step	€ 655,153 Cash 2024: € 655,153 ▲ € 600,228 vs 2023 (€ 54,925) Favourable step	€ 29,628 Cash 2025: € 29,628 ▼ 95% vs 2024 (€ 655,153) Unfavourable step	▼ 95%
Retained profit	€ 543,240 Retained profit 2022: € 543,240 First fiscal year in the series	€ 549,447 Retained profit 2023: € 549,447 ▲ 1% vs 2022 (€ 543,240) Favourable step	€ 720,977 Retained profit 2024: € 720,977 ▲ 31% vs 2023 (€ 549,447) Favourable step	€ 855,261 Retained profit 2025: € 855,261 ▲ 19% vs 2024 (€ 720,977) Favourable step	▲ 19%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 160,077 Dividend 2023: € 160,077 Unchanged (€ 0) Unchanged	€ 71,500 Dividend 2024: € 71,500 ▼ 55% vs 2023 (€ 160,077) Unchanged	€ 68,700 Dividend 2025: € 68,700 ▼ 4% vs 2024 (€ 71,500) Unchanged	▼ 4%
Bank debt	€ 52,469 Bank debt 2022: € 52,469 First fiscal year in the series	€ 91,362 Bank debt 2023: € 91,362 ▲ 74% vs 2022 (€ 52,469) Unfavourable step	€ 65,352 Bank debt 2024: € 65,352 ▼ 28% vs 2023 (€ 91,362) Favourable step	€ 38,675 Bank debt 2025: € 38,675 ▼ 41% vs 2024 (€ 65,352) Favourable step	▼ 41%
Balance sheet total	€ 669,842 Balance sheet total 2022: € 669,842 First fiscal year in the series	€ 784,942 Balance sheet total 2023: € 784,942 ▲ 17% vs 2022 (€ 669,842) Unchanged	€ 903,554 Balance sheet total 2024: € 903,554 ▲ 15% vs 2023 (€ 784,942) Unchanged	€ 943,138 Balance sheet total 2025: € 943,138 ▲ 4% vs 2024 (€ 903,554) Unchanged	▲ 4%

Key figures of DR. VERCAMMEN CHRIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VERCAMMEN CHRIS?

What happened at DR. VERCAMMEN CHRIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Chris Vercammen stepped down as director. NBB
Jul 9, 2026 New annual accounts for financial year 2025: profit of € 202,983 (▼ 16% vs 2024). Source: NBB ↗
2021 Chris Vercammen became a director. NBB
Jan 21, 2000 Start of the company according to the CBE. KBO
Jan 13, 2000 New establishment in Putte. KBO
Jan 13, 2000 New establishment in Bonheiden. KBO

In short

From € 117,765 profit in 2022 to € 202,983 profit in 2025.

Paid € 307,755 in corporate taxes since 2022.

Best year ever: 2024, with € 243,031 profit.

Paid out € 300,276 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

Chris Vercammen

Director

since 2021 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Wolzakken 22

2580 Putte

2.202.882.569

Imeldalaan 9

2820 Bonheiden

Active since 13 January 2000

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

associatie voor dialyse-endocrinologie

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0469.941.838

VAT number

BE 0469.941.838

Registered office

Wolzakken 22, 2580 Putte

Names & denominations

DR. VERCAMMEN CHRIS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 January 2000

Peppol

Active · Active since 15 Nov 2024

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van verpleegkundigen en verloskundigen

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

Verpleegkundige activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗